181 – 190 of 363
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2009
-
Mark
The non-coding RNA of the multidrug resistance-linked vault particle encodes multiple regulatory small RNAs.
(
- Contribution to journal › Article
-
Mark
IDENTIFICATION OF NOVEL SECRETED TUMOR STROMA-DERIVED STIMULATORS OF PROSTATE CANCER GROWTH
2009) 7th International Symposium on Targeted Anticancer Therapies In Annals of Oncology 20(Suppl 3). p.34-34(
- Contribution to journal › Published meeting abstract
-
Mark
Indistinguishable genomic profiles and shared prognostic markers in undifferentiated pleomorphic sarcoma and leiomyosarcoma: different sides of a single coin?
(
- Contribution to journal › Article
-
Mark
CXCL14 is an autocrine growth factor for fibroblasts and acts as a multi-modal stimulator of prostate tumor growth
(
- Contribution to journal › Article
-
Mark
Comparison of cisplatin sensitivity and the 18F fluoro-2-deoxy 2 glucose uptake with proliferation parameters and gene expression in squamous cell carcinoma cell lines of the head and neck
(
- Contribution to journal › Article
-
Mark
MiRNA expression in urothelial carcinomas: Important roles of miR-10a, miR-222, miR-125b, miR-7 and miR-452 for tumor stage and metastasis, and frequent homozygous losses of miR-31.
(
- Contribution to journal › Article
-
Mark
A Comprehensive Model for DNA Repair Genes and Radiation in Second Breast Cancers: The WECARE Collaborative Study Group
2009) 18th Annual Meeting of the International-Genetic-Epidemiology-Society In Genetic Epidemiology 33(8). p.189-189(
- Contribution to journal › Published meeting abstract
-
Mark
Analysis of a set of missense, frameshift, and in-frame deletion variants of BRCA1
(
- Contribution to journal › Article
- 2008
-
Mark
Gene products of chromosome 11q and their association with CCND1 gene amplification and tamoxifen resistance in premenopausal breast cancer.
(
- Contribution to journal › Article
-
Mark
Higher occurrence of childhood cancer in families with germline mutations in BRCA2, MMR and CDKN2A genes.
(
- Contribution to journal › Article